Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive disorder with an estimated
median survival time of 3–5 years after diagnosis. This condition occurs primarily in elderly …

Coronavirus disease 2019 (COVID-19) is associated with high risk of malnutrition, primarily
in older people; assessing nutritional risk using appropriate screening tools is critical. This …

Background Nintedanib is an approved therapy for idiopathic pulmonary fibrosis (IPF). Some
patients treated with nintedanib experience weight loss. Exploratory data suggest that low …

Introduction and aims Malnutrition is frequent in patients with idiopathic pulmonary fibrosis
(IPF). We examined the relationship between malnutrition at diagnosis and all-cause …

In idiopathic pulmonary fibrosis (IPF), several factors may have a negative impact on the
nutritional status, including an increased respiratory muscles load, release of inflammation …

Background Nutritional status impacts quality of life and prognosis of patients with
respiratory diseases, including idiopathic pulmonary fibrosis (IPF). However, there is a lack …

Phase angle (PhA) represents a raw variable measured with bioelectrical impedance
analysis (BIA) that is used to assess malnutrition in many diseases, including respiratory …

Background: Weight loss is frequently reported in patients with idiopathic pulmonary fibrosis
(IPF) and may be associated with worse outcomes in these patients. Objective: The aim of …

Background Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterised
by chronic fibrosis, and acute exacerbation of IPF (AE-IPF) is the leading cause of death in …

Interstitial lung diseases (ILD) are a heterogenic group of respiratory diseases with complex
pathogenesis. A growing number of evidence suggests role of adipose tissue and it's …